Seeking Alpha
Research analyst, IPOs, long/short equity
Profile| Send Message|
( followers)  

The following IPOs are expected to price this week:

Agios Pharmaceuticals (NASDAQ:AGIO), a biotech developing metabolic treatments for cancer and rare genetic diseases, plans to raise $75 million by offering 5.0 million shares at a price range of $14.00 to $16.00. At the midpoint of the proposed range, Agios Pharmaceuticals would command a market value of $441 million. Agios Pharmaceuticals, which was founded in 2007, booked $25 million in sales over the last 12 months. The Cambridge, MA-based company plans to list on the NASDAQ under the symbol AGIO. J.P. Morgan and Goldman Sachs are the joint bookrunners on the deal.

Cellular Dynamics International (NASDAQ:ICEL), which develops and manufactures functioning human cells in large quantities, plans to raise $50 million by offering 3.8 million shares at a price range of $12.00 to $14.00. At the midpoint of the proposed range, Cellular Dynamics International would command a market value of $212 million. Cellular Dynamics International, which was founded in 2004, booked $8 million in sales over the last 12 months. The Madison, WI-based company plans to list on the NASDAQ under the symbol ICEL. is the lead bookrunner on the deal.

Conatus Pharmaceuticals (NASDAQ:CNAT), a biotech developing treatments for chronic liver disease, plans to raise $55 million by offering 5.0 million shares at a price range of $10.00 to $12.00. At the midpoint of the proposed range, Conatus Pharmaceuticals would command a market value of $160 million. Conatus Pharmaceuticals was founded in 2005. The San Diego, CA-based company plans to list on the NASDAQ under the symbol CNAT. Stifel and Piper Jaffray are the joint bookrunners on the deal.

Graña y Montero (NYSE:GRAM), a largest engineering and construction company in Peru, plans to raise $350 million by offering 16.3 million shares at a price range of $19.70 to $23.30. At the midpoint of the proposed range, Graña y Montero would command a market value of $2.8 billion. Graña y Montero, which was founded in 1933, booked $2.0 billion in sales over the last 12 months. The Lima, Peru-based company plans to list on the NYSE under the symbol GRAM. Credit Suisse, J.P. Morgan, Morgan Stanley and BTG Pactual are the joint bookrunners on the deal. Please note: Shares already trade on the Lima Stock Exchange under ticker GRAMONC1.

Heat Biologics (NASDAQ:HTBX), which is developing cellular therapeutic vaccines for cancer therapy, plans to raise $25 million by offering 2.3 million shares at a price range of $10.00 to $12.00. At the midpoint of the proposed range, Heat Biologics would command a market value of $64 million. Heat Biologics, which was founded in 2008, booked $0 million in sales over the last 12 months. The Chapel Hill, NC-based company plans to list on the NASDAQ under the symbol HTBX. is the lead bookrunner on the deal.

Jones Energy (NYSE:JONE), a oil and gas E&P focused on the Anadarko and Arkoma basins of TX and OK, plans to raise $252 million by offering 14.0 million shares at a price range of $17.00 to $19.00. At the midpoint of the proposed range, Jones Energy would command a market value of $915 million. Jones Energy, which was founded in 1988, booked $191 million in sales over the last 12 months. The Austin, TX-based company plans to list on the NYSE under the symbol JONE. J.P. Morgan, Barclays and Wells Fargo Securities are the joint bookrunners on the deal.

Liquid Holdings Group (NASDAQ:LIQD), which provides an integrated software platform for hedge funds and asset managers, plans to raise $50 million by offering 5.0 million shares at a price range of $9.00 to $11.00. At the midpoint of the proposed range, Liquid Holdings Group would command a market value of $269 million. Liquid Holdings Group, which was founded in 2012, booked $4 million in sales over the last 12 months. The New York, NY-based company plans to list on the NASDAQ under the symbol LIQD. is the lead bookrunner on the deal.

Marlin Midstream Partners LP (NASDAQ:FISH), a spark Energy-affiliated LP formed to own midstream energy assets, plans to raise $125 million by offering 6.3 million shares at a price range of $19.00 to $21.00. At the midpoint of the proposed range, Marlin Midstream Partners LP would command a market value of $356 million. Marlin Midstream Partners LP, which was founded in 2013, booked $48 million in sales over the last 12 months. The Houston, TX-based company plans to list on the NASDAQ under the symbol FISH. Stifel, Baird and Oppenheimer & Co. are the joint bookrunners on the deal.

Onconova Therapeutics (NASDAQ:ONTX), a biotech focused on developing drug candidates for cancer and related diseases, plans to raise $60 million by offering 4.6 million shares at a price range of $12.00 to $14.00. At the midpoint of the proposed range, Onconova Therapeutics would command a market value of $261 million. Onconova Therapeutics, which was founded in 1998, booked $47 million in sales over the last 12 months. The Newtown, PA-based company plans to list on the NASDAQ under the symbol ONTX. Citi and Leerink Swann are the joint bookrunners on the deal.

Phillips 66 Partners LP (NYSE:PSXP), which Phillips 66 (NYSE:PSX)-backed limited partnership that owns pipeline and logistics assets, plans to raise $300 million by offering 15.0 million shares at a price range of $19.00 to $21.00. At the midpoint of the proposed range, Phillips 66 Partners LP would command a market value of $1.4 billion. Phillips 66 Partners LP, which was founded in 2012, booked $118 million in sales over the last 12 months. The Houston, TX-based company plans to list on the NYSE under the symbol PSXP. J.P. Morgan and Morgan Stanley are the joint bookrunners on the deal.

Silver Eagle Acquisition (NASDAQ:EAGLU), a blank check company focused on acquiring businesses in the media and entertainment industry, plans to raise $250 million by offering 25.0 million shares at a price range of $10.00 to $10.00. At the midpoint of the proposed range, Silver Eagle Acquisition would command a market value of $313 million. Silver Eagle Acquisition was founded in 2013. The Santa Monica, CA-based company plans to list on the NASDAQ under the symbol EAGLU. is the lead bookrunner on the deal.

WCI Communities (NYSE:WCIC), which develops luxury residential communities and homes in coastal Florida, plans to raise $185 million by offering 8.4 million shares at a price range of $21.00 to $23.00. At the midpoint of the proposed range, WCI Communities would command a market value of $568 million. WCI Communities, which was founded in 1946, booked $262 million in sales over the last 12 months. The Bonita Springs, FL-based company plans to list on the NYSE under the symbol WCIC. Citi, Credit Suisse and J.P. Morgan are the joint bookrunners on the deal.

Last week, there were 7 IPO pricings. OncoMed Pharmaceuticals (NASDAQ:OMED), a biotech developing new antibody therapeutics to be used in cancer treatments, was the week's winner, ending up 57% from its IPO price.

Source: 12 U.S. IPOs Planned For The Week Of July 22